PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.05%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-91.56%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-117.68%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
52.17%
Positive operating income growth while RUN is negative. John Neff might view this as a competitive edge in operations.
-19.73%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
5.26%
Positive EPS growth while RUN is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
-2636.84%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.11%
Share reduction more than 1.5x RUN's 0.61%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.11%
Slight or no buyback while RUN is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-16.64%
Negative OCF growth while RUN is at 68.72%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
37.43%
FCF growth above 1.5x RUN's 10.83%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-54.63%
Negative 10Y revenue/share CAGR while RUN stands at 266.29%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-19.07%
Negative 5Y CAGR while RUN stands at 40.50%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
52.14%
3Y revenue/share CAGR similar to RUN's 54.42%. Walter Schloss would assume both companies experience comparable short-term cycles.
-148.30%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
89.98%
5Y OCF/share CAGR above 1.5x RUN's 0.73%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
55.23%
Positive 3Y OCF/share CAGR while RUN is negative. John Neff might see a big short-term edge in operational efficiency.
-123.86%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
66.53%
Positive 5Y CAGR while RUN is negative. John Neff might view this as a strong mid-term relative advantage.
-181.28%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-72.89%
Negative equity/share CAGR over 10 years while RUN stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
707.78%
5Y equity/share CAGR above 1.5x RUN's 196.77%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
4083.36%
3Y equity/share CAGR above 1.5x RUN's 212.24%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.69%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-23.48%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-8.03%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-11.43%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-9.91%
We’re deleveraging while RUN stands at 6.45%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-16.93%
Our R&D shrinks while RUN invests at 10.58%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-79.07%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.